Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03393364 · ClinicalTrials.gov registry record · Early Phase 1
Pain Management in Outpatient Urologic Procedures
A Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 150
- Enrollment target
NCT03393364 is a Early Phase 1 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 150 participants.
The verdict
NCT03393364, a Early Phase 1 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 150 participants
- Enrollment target
Study Summary
Goal of this study is to evaluate how pain is controlled after outpatient urologic surgeries. Patients will receive either opioid pain medication or non-opioid medication for pain control. A survey will be conducted at the post-operative appointment to evaluate for pain control.
Interventions
- DRUG Ketorolac
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2020-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03393364
The ClinicalTrials.gov registry entry for NCT03393364 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT03393364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03393364 about?
NCT03393364 is a clinical study titled "Pain Management in Outpatient Urologic Procedures". Goal of this study is to evaluate how pain is controlled after outpatient urologic surgeries. Patients will receive either opioid pain medication or non-opioid medication for pain control. A survey will be conducted at the post-operative appointment to evaluate for pain control.
What is the current status of trial NCT03393364?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 150 participants. The study started on 2018-04-01. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03393364?
The interventions under investigation include: Ketorolac (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT03393364?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.